Peng Shen

3.3k total citations · 1 hit paper
71 papers, 2.1k citations indexed

About

Peng Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Peng Shen has authored 71 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 31 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Peng Shen's work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (13 papers) and MicroRNA in disease regulation (10 papers). Peng Shen is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (13 papers) and MicroRNA in disease regulation (10 papers). Peng Shen collaborates with scholars based in China, United States and Austria. Peng Shen's co-authors include Brian W. Loggie, Thomas F. Deuel, Yunchao Chang, Xintian Zhang, Zhaoyi Wang, Xin-Tian Zhang, Hao Yuan, Lingdong Meng, Kuirong Jiang and Yi Miao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Peng Shen

64 papers receiving 2.1k citations

Hit Papers

NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes ... 2023 2026 2024 2025 2023 25 50 75 100

Peers

Peng Shen
Chunxiao Zhou United States
Liang Chu China
Lijun Di China
Kaladhar B. Reddy United States
Yi Lü United States
Chunxiao Zhou United States
Peng Shen
Citations per year, relative to Peng Shen Peng Shen (= 1×) peers Chunxiao Zhou

Countries citing papers authored by Peng Shen

Since Specialization
Citations

This map shows the geographic impact of Peng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Shen more than expected).

Fields of papers citing papers by Peng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Shen. The network helps show where Peng Shen may publish in the future.

Co-authorship network of co-authors of Peng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Shen. A scholar is included among the top collaborators of Peng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Shen. Peng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chen, Zhigang Lei, Xiao Yang, et al.. (2025). Multimodal Assessment of Gentiopicroside's Protective Effect in CDCA-induced HepG2 Cell Injury. Journal of Visualized Experiments.
2.
Shen, Peng, Xuesong Mei, Xueshi Zhuo, et al.. (2024). Molecular dynamics simulations of microstructure and dislocation evolution of single-crystal Ni-based superalloys under femtosecond laser loading. Progress in Natural Science Materials International. 34(5). 942–954. 2 indexed citations
3.
Jia, Yunlu, Yongxia Chen, Ming Chen, et al.. (2024). Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axis. Cancer Letters. 611. 217423–217423. 2 indexed citations
4.
Yang, Jinhua, et al.. (2024). TFPN-mediated racemization/epimerization-free amide and peptide bond formation. Organic Chemistry Frontiers. 11(19). 5422–5428. 5 indexed citations
5.
Xu, Huawei, et al.. (2024). LINC00624 affects hepatocellular carcinoma proliferation and apoptosis through the miR‐342‐3p/DNAJC5 axis. Journal of Biochemical and Molecular Toxicology. 38(2). e23650–e23650.
6.
Guo, Qihao, et al.. (2024). Investigating the causal impact of gut microbiota on arthritis via inflammatory proteins using mendelian randomization. Scientific Reports. 14(1). 27433–27433. 4 indexed citations
7.
Yao, Wenjing, Peng Shen, Meng Yang, et al.. (2024). Integrated Analysis of microRNAs and Transcription Factor Targets in Floral Transition of Pleioblastus pygmaeus. Plants. 13(21). 3033–3033. 1 indexed citations
8.
Chen, Ming, Yinjing Song, Xiaochen Zhang, et al.. (2023). NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma. Cancer Letters. 567. 216285–216285. 105 indexed citations breakdown →
9.
Chen, Yongxia, Yunlu Jia, Misha Mao, et al.. (2021). PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer. Journal of Cellular and Molecular Medicine. 25(14). 6948–6962. 20 indexed citations
10.
Shen, Peng, Taoyue Yang, Qun Chen, et al.. (2021). CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing. Molecular Cancer. 20(1). 51–51. 92 indexed citations
11.
Wang, Qiuli, Liang Dong, Peng Shen, et al.. (2021). Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis. Translational Oncology. 14(8). 101045–101045. 45 indexed citations
12.
Ge, Wanli, Qun Chen, Lingdong Meng, et al.. (2020). The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Cell Death and Disease. 11(4). 294–294. 20 indexed citations
13.
Li, Wenyi, et al.. (2020). miR‐19 Is a Potential Clinical Biomarker for Gastrointestinal Malignancy: A Systematic Review and Meta‐analysis. BioMed Research International. 2020(1). 2810150–2810150. 7 indexed citations
14.
Shen, Peng, et al.. (2020). miR-335 Acts as a Tumor Suppressor and Enhances Ionizing Radiation-Induced Tumor Regression by Targeting ROCK1. Frontiers in Oncology. 10. 278–278. 10 indexed citations
16.
Shen, Peng, et al.. (2020). Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression. Cell Death and Disease. 11(5). 362–362. 30 indexed citations
17.
Shen, Peng, Rong Wang, Wen Jing, & Wenhua Zhang. (2010). Rice Phospholipase Dα is Involved in Salt Tolerance by the Mediation of H+-ATPase Activity and Transcription. Journal of Integrative Plant Biology. 53(4). 289–299. 37 indexed citations
18.
Fan, Xiaohui, et al.. (2005). Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods. PubMed. 2005. 6081–6084. 18 indexed citations
19.
Shen, Peng, et al.. (1993). Validation of the Species Concept in the Genus Dekkera by Restriction Analysis of Genes Coding for rRNA. International Journal of Systematic Bacteriology. 43(1). 32–35. 12 indexed citations
20.
Shen, Peng, et al.. (1992). Determination of infraspecific relationships in Kluyveromyces marxianus by riboprinting. Mycotaxon. 43. 49–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026